Background. The growing burden of neonatal mortality associated with hospital-acquired neonatal sepsis in the developing world creates an urgent need for cost-effective infection-control measures in resource-limited settings.
nosocomial pathogens. Institutional factors, especially inadequate resources to fund infection-control programs, also contribute to such transmission. Overuse of empirical antibiotic therapy is simultaneously a consequence of and a contributing factor to transmission [6] . A consequence of these factors has been the emergence of infection due to highly pathogenic multidrugresistant gram-negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) in neonatal intensive care units (NICUs) in developing countries, particularly in South and Southeast Asia [7] [8] [9] [10] . Simple, effective, and affordable infection-control interventions that are appropriate to settings in developing countries are urgently needed. In this context, we evaluated the effectiveness of a package of infection-control interventions at 2 NICUs in Manila, The Philippines; these interventions were selected because of their proven efficacy in the developed world and their perceived feasibility in the developing world [1] . Our primary outcome was the rate of new colonization with drug-resistant bacteria among neonates. Secondary outcomes included rates of bacteremia, mortality, and staff hand-hygiene compliance.
METHODS

Study setting.
We enrolled all neonates who were admitted to either NICU during the study period. The study was conducted at 2 inner-city, level-3 NICUs in Manila. The key baseline characteristics of the units are summarized in table 1. NICU 1 is located in the Philippines General Hospital, the largest public teaching hospital in The Philippines. NICU 2 is located in the José Fabella Memorial Hospital, a busy (∼100 deliveries per day) obstetrical and gynecological charity hospital. The protocol was approved by the Philippines General Hospital and Boston University Medical Center institutional review boards. Both NICUs accept only infants who are delivered at the respective hospitals.
Study design. The study used a quasi-experimental beforeand-after design. After a preparatory phase, we introduced the interventions in staggered fashion, as shown in figure 1 . Preparatory phase. Over 2 months, we standardized indications and procedures for blood cultures and microbiology laboratory procedures and trained our research assistants. A baseline survey generated site-specific guidance for finalization of the infection-control checklist.
Phase I: baseline surveillance. Our research assistants conducted 4 forms of surveillance. First, for each neonate, the assistants tracked the duration of NICU stay, use of vascular catheters and/or ventilators, dates and types of infection, and antibiotic use. Second, they conducted regular hand-hygiene compliance surveys. Third, they performed serial surveillance cultures for all neonates. Fourth, they documented all blood culture results.
Phase II: infection-control interventions. First, ethanol handrub at each basinet was prepared using locally purchased 70% ethanol mixed with glycerin as an emollient. Second, preparatory workshops for key staff at each unit were implemented at the onset of phase II. These workshops included lectures on hand hygiene and infection control, interactive case discussions, and a collaborative critique of a video of patient-staff interactions and infection-control activities at 1 of the NICUs. Third, (table 2) . Fourth, monthly infection-control checklists were used. The NICU attending physicians were responsible for implementation of these checklists (table 3) . Hand-hygiene assessments. No effort was made to blind NICU staff to the purpose of the observations. One-hour observations were performed intermittently during the day or night shift at a 2:1 ratio. A neonate was chosen, and then all hygiene encounters for that patient and the adjacent 2 neonates were monitored (3 neonates per observer period) [11] .
Laboratory methods. Quality-control procedures were established using standard American Type Culture Collection strains (George Mason University Research Laboratory). Gramnegative bacilli were categorized as enteric or nonenteric. Enteric bacteria were defined as bacteria for which the primary reservoir is the human gut, such as Escherichia coli. We defined nonenteric bacteria as bacteria that normally exist in the environment and only occasionally colonize the human gut, such as Pseudomonas aeruginosa.
Surveillance cultures. All neonates underwent screening for drug-resistant gram-negative bacilli and gram-positive cocci according to a standard schedule. Drug-resistant gram-negative bacilli were bacilli that were resistant to gentamicin and/or ceftazidime, and drug-resistant gram-positive cocci were MRSA or vancomycin-resistant enterococci (VRE). Culture of perianal swab and/or stool specimens were used for surveillance of gram-negative bacilli and VRE, and umbilical and anterior nare swab specimens (Culturette tubes, Becton Dickinson) were used for surveillance of MRSA. Surveillance for drug-resistant gramnegative bacilli commenced within 16 h after admission to an NICU (day 0) and was performed on days 2 and 7, every 7 days thereafter, and on the day of hospital discharge. The same schedule was used for screening for MRSA, omitting the day-0 cultures. The reason for gram-negative bacilli surveillance on day 0 was to determine the proportion of drug-resistant gramnegative bacilli colonization that occurred before NICU admission. Screening for drug-resistant gram-negative bacilli was performed with using MacConkey agar plates impregnated with 8 mg/mL of gentamicin or 2 mg/mL of ceftazidime. Screening to detect VRE was performed using bile-esculin agar plates with 6 mg/mL of vancomycin. Screening for MRSA was performed using Mueller-Hinton agar plates containing 6 mg/mL of oxacillin. Plates were incubated for 24 h at 35ЊC.
Blood culture. One milliliter of blood was inoculated in each blood culture bottle for each neonate with suspected bacteremia. Most clinical specimens were initially submitted to the respective microbiology laboratories at the 2 hospitals and were referred to the Philippines General Hospital research microbiology laboratory for confirmation and/or characterization with use of BACTEC (Becton Dickinson). Antibiotic susceptibility testing. For all screening of clinical isolates, we determined sensitivity by using Kirby-Bauer disk diffusion. Antibiotic susceptibility classifications were determined on the basis of National Committee for Clinical Laboratory Standards breakpoints [12] .
Statistical analyses. Analyses were conducted using SAS, version 9.2 (SAS Institute), and SPSS software, version 11 (SPSS). In our conceptual model of nosocomially acquired neonatal sepsis, we assumed that colonization typically preceeds invasive disease and that our interventions act primarily by interrupting transmission and, hence, colonization. In accordance with these assumptions, our primary outcome was the proportion of neonates who were newly colonized with the target bacteria (drug-resistant gram-negative bacilli or grampositive cocci). Therefore, we excluded cases of colonization or bacteremia during NICU days 0-1, under the assumption that these reflected pre-NICU exposures. We calculated the incidence density for colonization or confirmed bacteremia (first event per patient-days at risk) for each NICU separately. To prevent double counting of identical isolates, we included only the first new isolate from a given neonate, after which that neonate was censored for only that isolate. Subsequent colonizations with a different isolate were still included. In addition, we calculated incidence density for colonization and sepsis independent of each other. For example, if a neonate became colonized with a given isolate on day 2 and became bacteremic with that same isolate on day 4, the bacteremia calculation would not have been adjusted by censoring from the colonization event on day 2.
Secondary outcomes included rate of bacteremia (number of positive blood culture results per blood culture bottles submitted), incidence density of bacteremia (number of bloodstream infections per patient-days), cumulative mortality (number of NICU deaths per number of NICU admissions), and hand-hygiene compliance before and after implementation of the infection-control program (number of observed contacts between a health care provider and a neonate when appropriate cleansing with soap and water or ethanol handrub was performed per the total number of contacts).
The sample size was determined for our primary outcome. Assuming 10% baseline colonization, we estimated that 865 neonates per hospital would be needed to detect a 4% difference in colonization rate. Colonizations. As shown in table 4, most of the isolates confirmed by our colonization surveys were drug-resistant gram-negative bacilli. Among 8986 colonized swab specimens, 2903 drug-resistant bacterial isolates were detected; 2476 (85.3%) of these isolates were drug-resistant gram-negative bacilli, and 427 (14.7%) were drug-resistant gram-positive cocci (table 4) . Moreover, all 2476 drug-resistant gram-negative bacillus isolates were, a priori, detected in only the 4055 rectal swab and/or stool specimens; the crude positivity ratio was 61%. Many neonates (30.7%) had a stool and/or rectal specimen positive for drug-resistant gram-negative bacilli by culture on the date of NICU admission, which implied exposure during labor and delivery. Of the neonates who were not already colonized on NICU days 0-1, 45.6% became colonized with a drug-resistant gram-negative bacillus during hospitalization in the NICU. We identified 823 new colonizations with a gentamicin-resistant gram-negative bacillus and 771 new colonizations with ceftazidime-resistant gram-negative bacillus; 763 (92.7%) of the isolates were resistant to both drugs. Only 60 (7.3%) were resistant to gentamicin but not to ceftazidime, and only 8 isolates (0.9%) were resistant to ceftazidime but not to gentamicin.
RESULTS
Patient characteristics.
The 5 most common drug-resistant colonizing pathogens were Klebsiella pneumoniae (including K. pneumoniae pneumoniae and K. pneumoniae ozanae), Acinetobacter baumanii, P. aeruginosa, Enterobacter species, and E. coli. We identified 11 VRE isolates by culture of rectal specimens. MRSA was commonly isolated, particularly at NICU 2 (table 4) .
Colonization rates did not change significantly at either NICU between phase I and phase II (table 5), with regard to ceftazidime resistance and/or gentamicin resistance. Of interest, the types of detected gram-negative bacilli changed dramatically at both NICUs; there was an increase in enteric gram-negative bacilli and a decrease in nonenteric gram-negative bacilli (table  4) . At NICU 1, the ratio of enteric to nonenteric gram-negative bacilli was 40%:60% during phase I and 90%:10% during phase II ( ). At NICU 2, the ratio of enteric to nonenteric P ! .001 gram-negative bacilli was 52%:48% during phase I and 57%: 43% during phase II ( (table 6) . When we omitted duplicate isolates from the same neonate, 510 (40.4%) of 1262 blood culture results were positive. The dominant isolates were Klebsiella species, Enterobacter species, Pseudomonas species, and Alcaligenes faecalis (in approximately the same proportions as those found in the colonization surveys) (table 4). Similar to the colonization isolates, there was a shift from nonenteric to enteric gram-negative bacilli at both NICUs during phase II (ratio of enteric to nonenteric bacilli at NICU 1, 11%:89% during phase 1 vs. 72%:28% during phase 2;
; ratio of enteric to nonenteric bacilli P ! .001 at NICU 2, 68%:32% during phase I vs. 78%:22% during phase II;
). Among the gram-positive cocci that caused bac-P p .04 teremia, coagulase-negative staphylococci predominated (75%); there was only 1 MRSA isolate, and there were no VRE isolates. Fungemia was uncommon and was primarily due to non-Candida albicans Candida species.
Bacteremia rates at NICU 2 far exceeded those at NICU 1. However, after adjustment for patient-time at risk, overall bacteremia rates did not change at either unit between phase I and phase II (table 7) . However, this adjustment concealed a decrease in the number of cases of nonenteric bacteremia, particularly at NICU 1, and there was an absolute and relative increase in the number of cases of enteric bacteremia at both NICUs. In addition, NICU 1 experienced a small but statistically significant increase in the incidence of bacteremia due to coagulase-negative staphylococci and non-C. albicans Candida species.
NICU mortality. Mortality rates were high at both NICUs but decreased during phase II. Of 1828 neonates admitted to the NICU, 615 (33.6%) died. At NICU 1, the risk of death decreased during phase II (290 deaths per 1000 admissions during phase I vs. 144 deaths per 1000 admissions during phase II; RR, 0.50; 95% CI, 0.38-0.64); the absolute risk reduction was 15% (95% CI, 9%-20%). Mortality also decreased at NICU 2 during phase II (598 deaths per 1000 admission during phase I vs. 481 deaths per 1000 admissions during phase II; RR, 0.81; 95% CI, 0.71-0.91); the absolute risk reduction was 12% (95% CI, 6%-18%).
Hand-hygiene compliance. Hand-hygiene compliance improved at both NICUs during phase II (table 8) . Compliance was evaluated for a mean of 18 h per NICU per month; therefore, there were 513 1-h observations and 5423 patient contacts. In a comparison of phase II with phase I, the likelihood of precontact hand-hygiene compliance improved at both units (NICU 1: RR, 1.3; 95% CI 1.15-1.49; NICU 2: RR, 1.61; 95% CI, 1.40-1.86). The phase II interventions had no impact on the overall likelihood of postcontact hand-hygiene compliance at NICU 1 (RR, 0.94; 95% CI, 0.79-1.11), although there was a preferential shift toward ethanol-based handrub over soap and water ( ). At NICU 2, the likelihood of postcontact P ! .001 hand-hygiene compliance increased during phase II (RR, 1.6; 95% CI, 1.31-1.98), again with preferential use of ethanol-based handrub ( ). P p .01
DISCUSSION
This project tested the effectiveness of a package of infectioncontrol interventions at 2 of the largest NICUs in The Philippines. The interventions were associated with an increased rate of hand-hygiene compliance in general and of alcoholbased handrub use in particular. However, the overall incidences of colonization with resistant bacteria and of bacteremia were unchanged. Therefore, although mortality rates decreased substantially, we were unable to conclude that the interventions were responsible for the decreases.
Our data provide some bleak insights into the epidemiology of drug-resistant bacteria at these NICUs: colonization pressure with drug-resistant pathogens was intense, with correspondingly high rates of bacteremia and mortality. Moreover, the spectrum of pathogens causing sepsis was remarkable for its dissimilarity to the spectrum at NICUs in the developed world. Four of the most common pathogens were nonenteric pathogens: A. baumanii, P. aeruginosa, Stenotrophomonas maltophilia, and A. faecalis (an uncommon pathogen that is rarely reported in the developing world) [13] [14] [15] . The high frequency of nonenteric gram-negative bacilli and the high rates of drug resistance strongly imply that nosocomial transmission, rather than mother-to-child transmission during delivery, was responsible for colonization. MRSA colonization was common (although sepsis was rare), and VRE appeared to be an emerging threat, which is worrisome, given the lack of prior reports of VRE infection in The Philippines.
The agents that most commonly cause early neonatal sepsis in the developed world are group B streptococci (GBS) and E. coli. However, in our study, GBS sepsis was conspicuous for its absence, echoing results from the International Infections in Pregnancy study group, which found GBS colonization rates to be one-half of those found in Dublin, Ireland, and one-third of those found in Philadelphia [16, 17] . A recent review by Zaidi et al. [18] of hospital-acquired neonatal sepsis in developing nations also found GBS in only 2.3% of sepsis episodes. This is problematic because current guidelines for neonatal sepsis, such as the World Health Organization's pocket manual for the management of hospital illnesses in resource-poor countries [19] , assume that GBS and fully drug-susceptible enteric gram-negative bacilli are the primary agents that cause early neonatal sepsis.
Thirty percent of neonates arrived at the 2 NICUs already colonized with drug-resistant gram-negative bacilli. This finding prompted us to go beyond the plan of the study and investigate what conditions and/or practices in the labor and delivery unit might be contributing to transmission. Several possibilities emerged; one was that latex gloves, frequently in short supply, were often rinsed and reused after air-drying on a rack. We also noted that it was standard practice for obstetricians to swab each mother's perineum with povidone-iodine before delivery. These solutions were decanted from open largenecked containers into multiuse bottles. P. aeruginosa and other environmental gram-negative bacilli can be resistant to povidone-iodine. Therefore, contamination of the stock supplies could systematically expose the neonates to iodine-resistant pathogens during delivery [20] [21] [22] . Additional environmental studies would be helpful to test these observations and identify other potential exposure sources.
We observed a shift from nonenteric to enteric gram-negative bacilli isolates during phase II, particularly at NICU 1. Because this shift occurred among both the invasive isolates and the colonizing isolates, it probably represents a true shift in the epidemiology of these nosocomial pathogens. Whether this occurred because of our interventions or because of factors external to our study is unclear.
The rate of hand-hygiene compliance at the start of the project was low but improved over time at both NICUs. Moreover, the modest absolute increase in hand-hygiene compliance rates concealed a much larger proportional increase in ethanol-based handrub use, a modality vastly superior to soap and water [23, 24] . Although it was discouraging that hand-hygiene compliance rates did not increase more, such results are typical [11] .
In a trial at Children's Hospital Boston (Boston, MA), Harbarth et al. [25] saw the rate of hand-hygiene compliance increase after their intervention, but the effect was transient-the rate decreased from 42.5% to 35.1% within months after their study began. Other studies documented postintervention compliance rates as low as 14% [26] , although typical postintervention compliance rates are 40%-60% [11] . Such findings emphasize the variability in responses to behavioral interventions and the enormous challenges inherent in effecting sustained behavioral change. Ultimately, we were unable to conclude definitively that our interventions were effective. On one hand, improvements in hand hygiene compliance demonstrate the feasibility of infection control through behavioral change in a resource-limited setting. Furthermore, mortality decreased significantly at both NICUs during phase II, which was a positive, although surprising, outcome. On the other hand, our conceptual model assumes that improved hand hygiene reduces colonization pressure, with decreased bacteremia and mortality rates being downstream effects. The fact that colonization and bacteremia rates remained stable during phase II conflicts with this model and calls into question whether our interventions or external factors caused mortality rates to decrease; the result in our study was similar to that in a recent study by Rupp et al. [27] , in which hygiene compliance improved without changing transmission rates. A notable exception was the disappearance of MRSA colonization from NICU 2 during phase II. This was surprising and hard to reconcile because of the very high rates of MRSA colonization during phase I at NICU 2 and stable MRSA colonization rates at NICU 1.
Our study had 2 main limitations. First, before-and-after comparisons are inherently vulnerable to confounding by intercurrent seasonal or secular events. However, randomization would have been realistic only in the context of a large multicenter trial. Second, resource constraints did not allow us to collect process indicators to monitor whether other aspects of our intervention, such as the daily and monthly checklists, were being implemented as intended.
In conclusion, this study at 2 of the largest NICUs in The Philippines demonstrates that enhanced infection-control interventions are feasible and possibly effective in developing settings. The epidemiology of neonatal sepsis at these NICUs is characterized by intense colonization pressure with multi-drug-resistant gram-negative bacilli, with correspondingly high rates of bacteremia and mortality. Additional analyses have been conducted to better characterize these pathogens and to identify factors related to the transmission of drug-resistant gram-negative bacilli at these NICUs. MRSA and VRE appear to be emerging threats. By contrast, the absence of GBS suggests that this pathogen is unimportant in this context. Reducing the burden of drug-resistant nosocomial infections in developing hospital settings must be a priority for regional and global public health agencies. Additional research is needed to understand what kinds of barriers to improving hand-hygiene compliance exist for the staff at these NICUs, to identify reservoirs for environmental pathogens as a key step in interrupting their transmission, and to explore the cost implications of implementing infection-control programs in resource-poor hospitals.
